X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/15/2882852/0/en/Celcuity-Inc-Reports-First-Quarter-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/08/2877694/0/en/Celcuity-Inc-Schedules-Release-of-First-Quarter-2024-Financial-Results-and-Webcast-Conference-Call.html
https://www.globenewswire.com/news-release/2024/04/04/2857655/0/en/Celcuity-To-Present-at-Upcoming-Needham-and-Stifel-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/03/27/2853589/0/en/Celcuity-Inc-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/20/2849240/0/en/Celcuity-Inc-Schedules-Release-of-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Webcast-Conference-Call.html
https://www.globenewswire.com//news-release/2024/03/06/2841271/0/en/Celcuity-to-Participate-in-Leerink-Partners-Global-Biopharma-Conference-2024.html
https://www.globenewswire.com//news-release/2024/02/28/2836824/0/en/Celcuity-to-Participate-in-Cowen-s-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/22/2834087/0/en/Celcuity-Announces-First-Patient-Dosed-in-Phase-1b-2-CELC-G-201-Clinical-Trial-of-Gedatolisib-for-the-Treatment-of-Metastatic-Castration-Resistant-Prostate-Cancer.html
https://www.globenewswire.com//news-release/2024/02/20/2831689/0/en/Celcuity-Appoints-Eldon-Mayer-as-Chief-Commercial-Officer.html
https://www.globenewswire.com/news-release/2023/12/06/2791761/0/en/Celcuity-Presents-Preclinical-Data-on-Therapeutic-Effects-of-Gedatolisib-in-Breast-Cancer-Models-at-the-2023-San-Antonio-Breast-Cancer-Symposium.html
Market Place
Share 
